Randomized clinical trial “olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin”: preliminary results - D’Ascanio, L; Vitelli, F; Cingolani, C (Eur Rev Med Pharmacol Sci, 2021)
et al.